Posters

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30

Sunday, September 28

4:45 PM - 6:00 PM PT

2526 - Voxel-Based Analysis of Cardiac Radiosensitivity: Impact of Consolidation Immunotherapy after Chemoradiotherapy
Speaker: Yoon, Hong In, MD, PhD - Yonsei University College of Medicine, Seoul, Seoul
4:45 PM - 6:00 PM PT

2527 - Prediction of Oligometastatic Disease from Breast Cancer Using Next Generation Sequencing Genomics
Speaker: Young, Patrick, DO - Atrium Health Wake Forest Baptist, Winston-Salem, NC
4:45 PM - 6:00 PM PT

2528 - A Temporal Perspective: Charting and Predicting Treatment Response in Breast Cancer-Related Lymphedema
Speaker: Yu, Enoch, BS - Queen's University, Kingston, ON
4:45 PM - 6:00 PM PT

2529 - Efficacy and Safety of Hypofractionated Radiotherapy Plus Sequential Chemotherapy with Immunotherapy in Patients with Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer
Speaker: Yu, Yue - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, China/Beijing
4:45 PM - 6:00 PM PT

2530 - Stiff Matrix Promotes Radioresistance in Lung Cancer via the Rho/ROCK-YAP/TEAD4 Signaling Axis
Speaker: Yuan, Meng, MD - None, Beijing, Beijing
4:45 PM - 6:00 PM PT

2531 - Harnessing Lactate-Efflux Inhibition to Sensitize Radiotherapy: A Metabolic-Immune Dual-Targeting Strategy for NSCLC
Speaker: Yuan, Wenqian, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan, Hubei
4:45 PM - 6:00 PM PT

2532 - A Phase II Trial of Safety and Efficacy of Radiotherapy Combined with Anlotinib in Locally Advanced Non-Small Cell Lung Cancer Patients Intolerable to Concurrent Chemoradiotherapy: Preliminary Survival Analysis
Speaker: Yuan, Yupei, MD, MS - Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing
4:45 PM - 6:00 PM PT

2533 - Prophylactic Cranial Irradiation in Resected Early Stage Small Cell Lung Cancer: An Updated Systematic Review and Meta-Analysis
Speaker: Yuan, Ze, MD - Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China
4:45 PM - 6:00 PM PT

2534 - High PD-L1 Expression is Associated with Adaptive Replanning in Patients with Locally Advanced (LA) Non-Small Cell Lung Carcinoma (NSCLC) Treated with Chemoradiotherapy (chemoRT)
Speaker: Zagelbaum, Jennifer, MD, PhD - Harvard Radiation Oncology Program, Boston, MA
4:45 PM - 6:00 PM PT

2535 - OIP5 Mediates Radiotherapy Resistance in Lung Adenocarcinoma through POLD1-Dependent DNA Damage Repair
Speaker: Zeng, Siwei - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing
4:45 PM - 6:00 PM PT

2536 - Comparison of Scanning Beam Proton Therapy vs. Photon IMRT in Patients with Locally Advanced Non-Small Cell Lung Cancer
Speaker: Zerfu, Model, BS - University of Washington-Fred Hutchinson Cancer Center, Seattle, WA
4:45 PM - 6:00 PM PT

2537 - Definitive Chemoradiation Therapy Followed by Immunotherapy (PACIFIC Regimen) in Stage III Large Cell Carcinoma: Assessing Efficacy Relative to Other Major Non-Small Cell Lung Cancer Subtypes
Speaker: Zhang, Chi, MD, PhD - Mayo Clinic Arizona, Phoenix, AZ